Talk:Dexcom CGM

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Low	This article has been rated as Low-importance on the project's importance scale.

Technology

This article is within the scope of WikiProject Technology, a collaborative effort to improve the coverage of technology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.TechnologyWikipedia:WikiProject TechnologyTemplate:WikiProject TechnologyTechnology

Did you know nomination

(

Comment or view
Article history

)

... that the Dexcom G6 was the first continuous glucose monitor to function without requiring calibrations, thereby eliminating the need for regular fingerstick blood tests?

Source: 1. https://pmc.ncbi.nlm.nih.gov/articles/PMC6477582/ "...the FDA approved the Dexcom G6 as the first real-time factory-calibrated CGM system..." 2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6422005/ "...sixth-generation factory-calibrated real-time CGM (rtCGM) system (G6) was developed..."

ALT1: ... that the Dexcom Seven, launched in 2007, was the first CGM system capable of delivering continuous glucose data for a full seven days, doubling the lifespan of its predecessor?

Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC8120065/ "...the STS-7, which was the first device to allow patients to continuously monitor their glucose levels for seven days as opposed to three."

ALT2: ... that Dexcom aired its first-ever Super Bowl ad in 2023, featuring Nick Jonas, who lives with type 1 diabetes and uses the Dexcom G7 CGM?

Source: https://www.drugdeliverybusiness.com/dexcom-us-g7-launch-super-bowl-nick-jonas/ "The ad, set to run during the second quarter of Super Bowl LVII on Feb. 12, features musician, actor and philanthropist Nick Jonas. Jonas lives with type 1 diabetes..."

ALT3: ... that the Dexcom Follow app enables up to ten designated users—like parents or caregivers—to remotely monitor a person’s real-time glucose readings on their mobile devices?

Source:https://www.dexcom.com/apps

Reviewed:

Created by MallardTV (talk). Number of QPQs required: 0. Nominator has fewer than 5 past nominations.

MallardTV ^{Talk to me!} 23:36, 6 April 2025 (UTC).[reply]

General: Article is new enough and long enough
New enough: Long enough:

Policy: Article is sourced, neutral, and free of copyright problems
Adequate sourcing: Neutral: Free of copyright violations, plagiarism, and close paraphrasing:

Hook: Hook has been verified by provided inline citation
Cited: Interesting:

QPQ: Done.

Overall: So far so good, article passed minimum length criterion and newness. Source spot checks indicate good results, though I don't think every product name needs to be bolded? I would AGF on the interpretation that "first real-time factory-calibrated CGM system" means "without requiring calibrations". I also endorse the ALT0 hook, though I think it would be much more compact if you end the hook at "...calibrations" (no need for the "thereby eliminating the need for regular fingerstick blood tests?"). Approved! Regards, Jeromi Mikhael 04:32, 29 April 2025 (UTC)[reply]

Pulled per concerns raised at WT:DYK#Queue 5 (7 May, 00:00). A new hook will be needed here, one that is less likely to be challenged and also one that may not be perceived as advertising. Narutolovehinata5 (talk · contributions) 12:29, 5 May 2025 (UTC)[reply]

ALT2 may be better, it is easily verifiable and just as interesting. MallardTV ^{Talk to me!} 13:13, 5 May 2025 (UTC)[reply]

Suggestion from our Discord discussion:

ALT2a: ... that a 2023 Super Bowl ad featured Nick Jonas using a Dexcom G7 CGM?

I think this is just as interesting, shorter, and a bit less promotional. jlwoodwa (talk) 03:04, 10 May 2025 (UTC)[reply]

On second thought, I might have trimmed this a bit too much, at the expense of meaning anything to someone unfamiliar with the subject matter. Perhaps a mention or link to type 1 diabetes should find its way back into the hook somewhere. jlwoodwa (talk) 03:12, 10 May 2025 (UTC)[reply]

ALT2b: ... that a 2023 Super Bowl ad featured Nick Jonas, a type one diabetic, using a Dexcom G7 CGM?

@Jeromi Mikhael: as the original reviewer, can you determine if ALT2a or ALT2b are approved? If not, please outline your concerns. Z1720 (talk) 14:53, 26 May 2025 (UTC)[reply]

@MallardTV, Narutolovehinata5, Jlwoodwa, Jeromi Mikhael, and Z1720: Jumping in as it's been a week without comment; the source is in future tense and does not confirm it actually happened.--Laun chba ller 21:42, 2 June 2025 (UTC)[reply]

I can find another source. Here: https://investors.dexcom.com/news/news-details/2023/Dexcom-and-Nick-Jonas-Make-Super-Bowl-Magic-to-Launch-New-Dexcom-G7-Continuous-Glucose-Monitoring-System/default.aspx MallardTV ^{Talk to me!} 26:46, 3 June 2025 (UTC).[reply]

I don't think Dexcom are an appropriate source for that.--Laun chba ller 21:01, 3 June 2025 (UTC)[reply]

how about https://admeter.usatoday.com/story/sports/ad-meter/2023/02/07/nick-jonas-magic-dexcom-super-bowl-57-2023/77668440007/?

Still future tense I'm afraid. It says "The ad is set to run during a 30-second spot in the second quarter of the Big Game", emphasis mine.--Laun chba ller 10:09, 4 June 2025 (UTC)[reply]

https://www.billboard.com/culture/tv-film/nick-jonas-super-bowl-commercial-2023-dexcom-g7-1235252549/ -MallardTV

Excellent. Now let's see it in the article.--Laun chba ller 12:56, 4 June 2025 (UTC)[reply]

Let's roll.--Laun chba ller 17:08, 4 June 2025 (UTC)[reply]